Advertisement
Heart, Lung and Circulation

Changing Practice: Procedural Volume of Transcatheter Aortic Valve Implantation by Age and Funding in New South Wales, 2002–2018

Published:October 13, 2021DOI:https://doi.org/10.1016/j.hlc.2021.09.010
      Transcatheter aortic valve replacement (TAVI) was first subsidised by Medicare in 2017 for inoperable patients or those too high-risk for surgical aortic valve replacement (SAVR). Internationally, TAVI guidelines have expanded to include intermediate-risk patients, despite limited long-term trial evidence. Lee et al. [
      • Lee A.H.
      • Ng A.C.C.
      • Yong A.S.C.
      • Hyun K.
      • Brieger D.
      • Kritharides L.
      • et al.
      Outcomes of 1,098 patients following transcatheter aortic valve implantation: a statewide population-linkage cohort study.
      ] recently reported that the number of TAVI in New South Wales (NSW) increased 10-fold between 2013 and 2017.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lee A.H.
        • Ng A.C.C.
        • Yong A.S.C.
        • Hyun K.
        • Brieger D.
        • Kritharides L.
        • et al.
        Outcomes of 1,098 patients following transcatheter aortic valve implantation: a statewide population-linkage cohort study.
        Heart Lung Circ. 2021; 30: 1213-1220
        • Sedrakyan A.
        • Dhruva S.S.
        • Sun T.
        • Mao J.
        • Gaudino M.F.
        • Redberg R.F.
        Trends in use of transcatheter aortic valve replacement by age.
        JAMA. 2018; 320: 598-600
        • Ali N.
        • Faour A.
        • Rawlins J.
        • Dawkins S.
        • Appleby C.E.
        • MacCarthy P
        • et al.
        ‘Valve for Life’: tackling the deficit in transcatheter treatment of heart valve disease in the UK.
        Open Heart. 2021; 8: e001547
        • NSW Treasury
        Outcomes Statement 2021-22.
        NSW Treasury, 2021 (Budget Paper No. 2. Sydney)

      Linked Article